Global Pruritus Therapeutics Market Size study & Forecast, by Drug Type (Corticosteroids, Antihistamines, Local Anesthetics, Immunosuppressant, Others), by Disease Type (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Others), by Distribution C

Global Pruritus Therapeutics Market Size study & Forecast, by Drug Type (Corticosteroids, Antihistamines, Local Anesthetics, Immunosuppressant, Others), by Disease Type (Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria, Others), by Distribution Channel (Hospital Pharmacies, Drug stores & Retail Pharmacies, Online providers) and Regional Analysis, 2022-2029

Global Pruritus Therapeutics Market is valued at approximately USD 7.9 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 3.6% over the forecast period 2022-2029. Pruritus is a medical term for itchy skin. Most of the itchy skin conditions are associated with Dry skin, allergies, and underlying Skin disease. Moreover, certain types of pruritus are associated with various diseases including cancer, diabetes, HIV, liver & gallbladder diseases among others. This condition can be treated using oral treatments. The increasing prevalence of skin diseases worldwide and growing emergence of e-pharmacy as well as strategic initiatives from leading market players are key factors accelerating the market growth.

The increasing incidences of skin disorders such as Atopic Dermatitis, Allergic Contact Dermatitis, Urticaria are contributing to the growth of the Global Pruritus Market. For instance, according to the National Center for Biotechnology Information (NCBI) – as of 2019, in Europe about 20% of the general population is affected by contact allergies. Moreover, as per World Allergy Organization – as of 2020, globally contact dermatitis accounts for approximately 85 – 95% of all occupational skin diseases in industrialized countries and contributes to an estimated 5.7 million physician visits per year. Also, growing healthcare infrastructure in developing regions and rising number of geriatric individuals would create a lucrative growth prospectus for the market over the forecast period. However, lack of awareness towards underlying disease stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Pruritus Therapeutics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region in terms of market share owing to growing prevalence of skin disorders as well as presence of leading pharmaceutical companies in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric population and rising expansion of pharmaceutical sector in the region.

Major market players included in this report are:
AbbVie Inc.
Amgen Inc.
Bausch Health Companies Inc.
Cara therapeutics, Inc.
Cipla Ltd.
Eilly Lilly and company
Evelo Biosciences
Galderma S.A.
LEO Pharma
MC2 therapeuitics

Recent Developments in the Market:
 In August 2021, Cara Therapeutics received FDA approval for its (CARA.O) drug to treat moderate-to-severe itching in patients undergoing dialysis with chronic kidney disease.


Global Pruritus Therapeutics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Drug Type, Disease Type, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
The detailed segments and sub-segment of the market are explained below:

By Drug Type
Corticosteroids
Antihistamines
Local Anesthetics
Immunosuppressant
Others

By Disease Type
Atopic Dermatitis
Allergic Contact Dermatitis
Urticaria
Others

By Distribution Channel
Hospital Pharmacies
Drug stores & Retail Pharmacies
Online providers

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned

AbbVie Inc.
Amgen Inc.
Bausch Health Companies Inc.
Cara therapeutics, Inc.
Cipla Ltd.
Eilly Lilly and company
Evelo Biosciences
Galderma S.A.
LEO Pharma
MC2 therapeuitics

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.